![]() |
|
|
M Floreani, A Forlin, L Pandolfo, M Petrone and S Bellin
Department of Pharmacology, University of Padova, Italy.
In electrically driven guinea pig left atria, plumbagin (5-hydroxy-2- methyl-1,4-naphthoquinone; 0.5-10 microM) produced a marked positive inotropic effect that was about 65% that caused by isoprenaline in the same experimental conditions. The effect was mainly not dependent on catecholamine release from adrenergic stores. An EC50 of 3 microM was calculated from the concentration-response curves. The increase in force of contraction was followed by a nonreversible contracture. Plumbagin was reduced by cardiac mitochondrial and soluble reductases with consequent generation of large amounts of superoxide anion. The assay of reduced glutathione/oxidized glutathione content in atria, treated with 10 microM plumbagin and frozen at the appearance of increase in diastolic tension, showed a significant decrease in reduced glutathione (-52% with respect to control atria) and a 5-fold increase in oxidized glutathione levels. Moreover, in the same experimental conditions a significant decrease in adenosine triphosphate (-55% with respect to the controls) and in adenylate energy charge (from 0.92- 0.64) was observed. Of the enzymes and transport systems involved in the control of the cardiac contractility, the sarcoplasmic reticulum Ca2+ pump seemed to be a specific target for plumbagin. After 30 min of incubation with cardiac sarcoplasmic reticulum membrane vesicles, plumbagin inhibited Ca2+ uptake by the pump in a concentration- dependent manner (IC50 = 3 microM). On the basis of these results, the increase in diastolic tension caused by plumbagin appears to be related to intracellular Ca2+ accumulation, due both to the low availability of adenosine triphosphate for ionic pumps and direct inhibition of Ca2+ reuptake in sarcoplasmic reticulum.
This article has been cited by other articles:
![]() |
V. M. Bulatovic, N. L. Wengenack, J. R. Uhl, L. Hall, G. D. Roberts, F. R. Cockerill III, and F. Rusnak Oxidative Stress Increases Susceptibility of Mycobacterium tuberculosis to Isoniazid Antimicrob. Agents Chemother., September 1, 2002; 46(9): 2765 - 2771. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Zoeller, T. J. Grazia, P. LaCamera, J. Park, D. P. Gaposchkin, and H. W. Farber Increasing plasmalogen levels protects human endothelial cells during hypoxia Am J Physiol Heart Circ Physiol, August 1, 2002; 283(2): H671 - H679. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Dorigo, M. Floreani, G. Santostasi, I. Maragno, D. Danieli-Betto, E. Germinario, S. M. Magno, G. Primofiore, A. M. Marini, and F. Da Settimo Pharmacological Characterization of a New Ca2+ Sensitizer J. Pharmacol. Exp. Ther., December 1, 2000; 295(3): 994 - 1004. [Abstract] [Full Text] |
||||
![]() |
M. Floreani, P. A. Borea, S. Gessi, L. Mosti, P. Fossa, and P. Dorigo A New Milrinone Analog: Role of Binding to A1 Adenosine Receptor in its Positive Inotropic Effect on Isolated Guinea Pig and Rat Atria J. Pharmacol. Exp. Ther., November 1, 1997; 283(2): 541 - 547. [Abstract] [Full Text] |
||||